ULK1 and neoplasm: To further investigate the effect of ULK1 knockout on the effect of MDM2i in vivo, we subcutaneously implanted tumor cells with ULK1 knockout in nude mice and began treating the mice with APG-115 every two days from day 4 after cell implantation (Fig. 2E).